The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment.
Purpose :To investigate whether the rate of infiltration of local anaesthetic influences the pain or efficacy of
local anaesthesia in oculoplastic surgery.Methods :A prospective observational study on consecutive patients undergoing a variety of oculoplastic procedures under
local anaesthesia. An observer recorded the rate of injection of local anaesthetic during each procedure. The same mixture
of local anaesthetic and the same needle gauge was used in all cases. Patients were asked to rate the pain of both the
injection and the surgery using a visual analog scale (VAS).Results :77 consecutive patients were observed, 39/77 (50.6%) patients were female and the average age was 63.5 years
(range 31-94). A statistically significant correlation was found between the rate of injection and the VAS score from the
injection (p<0.0001, r=0.42). There was no significant correlation between the injection rate and the VAS score from the
procedure itself (p=0.25, r=0.13). Additionally, a significant correlation was found between the injection VAS score and
the procedure VAS score (p=0.0002, r=0.42).Conclusion :The slower the rate of injection of local anaesthetic, the less pain was reported by the patient from the
injection itself. Indeed the perception of pain from the surgery overall was significantly related to the pain felt during the
injection, highlighting the importance of minimising pain during the injection of the local anaesthetic. We conclude that
slowing the rate of injection is an effective way of alleviating pain from administration of the anaesthetic.
Background
Whilst research and innovation is embedded within the UK’s National Health Service (NHS) constitution, Doctors-in-training have little opportunity to contribute to designing, leading and recruiting into clinical trials or cohort studies. We formed the West MidlandsCollaborativeOphthalmologyNetwork forClinicalEffectiveness &Research byTrainees (The West Midlands CONCERT) and undertook a characterisation of post cataract surgery endophthalmitis as a proof-of-concept study to test the feasibility of the CONCERT model.
Methods
Doctors-in-training formed a collaborative working group to test the concept of delivering a pan-regional clinical effectiveness study across multiple hospital sites by performing retrospective analyses of post cataract endophthalmitis over a 6-year period.
Results
Overall, 157,653 cataract surgeries were performed by participating centres accredited to deliver the Royal College of Ophthalmologists training curriculum. Thirty-eight cases of post cataract endophthalmitis were identified, giving an incidence of 2.41 per 10,000 cases (0.0241%). A further 15 endophthalmitis cases presented who had surgery in non-training centres, giving a total of 53 cases. The most common organisms were S. epidermidis (14 (51.9%)) and P. aeruginosa (5 (18.5%)). Anterior-chamber and vitreous sampling yielded positive culture in 33.3% (6/18) and 50.9% (27/53), respectively. At 6 months follow-up, 19 (51.4%) patients achieved visual acuities of ≤0.5 LogMAR. Repeat intravitreal injections (11 (20.8%)) and vitrectomy (n = 22 (41.5%)) were not associated with better outcomes.
Conclusions
Using post cataract endophthalmitis as a pilot cohort, this study highlights the feasibility of using the CONCERT model for studies across multiple sites. A UK-CONCERT could provide a powerful infrastructure enabling characterisation of patient cohorts and a platform for high-quality interventional studies, improving patient care.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.